CRP and Parkinson disease: Additionally, across the time course of the disease, patients with PD exhibit higher systemic and CSF CRP levels compared to healthy controls (13) and, independent of disease duration or symptom severity, baseline CRP levels in patients with PD are associated with risk of death and predicted life prognosis (29).